Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|August 17, 2000
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumorsM Toyota, L Shen, M Ohe-Toyota, et al.
Cancer|December 1, 1994
Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapseF A Sinicrope, J Hart, T A Brasitus, et al.
Cancer Research|January 15, 1995
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesisF A Sinicrope, S B Ruan, K R Cleary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2020
Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)H Lee, D Sha, N R Foster, et al.
Gastroenterology|July 27, 1999
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancersF A Sinicrope, M Lemoine, L Xi, et al.
Oncology Reports|April 16, 1999
Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancerM L Frazier, F A Sinicrope, C I Amos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancersF A Sinicrope, G Roddey, M Lemoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]B Saberzadeh-Ardestani, N R Foster, H E Lee, et al.
British Journal of Cancer|June 3, 2015
MiR-320e is a novel prognostic biomarker in colorectal cancerL Perez-Carbonell, F A Sinicrope, S R Alberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1996
bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcomeF A Sinicrope, D B Evans, S D Leach, et al.
Pageof 3